For instance, in nasopharyngeal carcinoma, HMGB1 enhances the non-homologous end-joining (NHEJ) DNA repair pathway through interaction with Ku70, contributing to resistance to both radiotherapy and cisplatin. Here, XRCC6 is linked to nasopharyngeal carcinoma.